Inter-fraction prostate motion during intensity-modulated radiotherapy for prostate cancer

被引:0
|
作者
Siow, T. R. [1 ]
Ngoi, C. L. F. [1 ]
Tan, W. K. T. [1 ]
机构
[1] Natl Canc Ctr Singapore, Dept Radiat Oncol, Singapore 169610, Singapore
关键词
fiducial markers; intensity-modulated radiotherapy; inter-fraction motion; prostate cancer; PORTAL IMAGING DEVICE; RADIOPAQUE MARKERS; ERRORS; LOCALIZATION; IRRADIATION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: This study aimed to analyse the inter-fraction prostate motion and setup error during intensity-modulated radiotherapy for prostate cancer at the National Cancer Centre Singapore. Methods: Gold seeds were implanted as fiducial markers. Daily portal films were taken and displacements of the gold seeds from the isocentre in each axis were recorded. Random and systematic errors were used to derive a margin recipe for each axis based on the van Herk formula. Results: 1,077 fractions from 36 patients were analysed. 89.8 percent, 85.2 percent and 83.6 percent of the setup errors were within +/- 2 mm for the right-left (RL), superior-inferior (SI) and anterior-posterior (AP) axes, respectively. The population systematic errors were 0.71 mm, 0.84 mm and 0.87 mm; the population random errors were 1.32 mm, 1.59 mm and 1.70 mm; the overall population mean setup errors were -0.14 (range -2.27 to 1.15) mm, 0.11 (range -2.32 to 1.69) mm and 0.08 (range -1.33 to 1.46) mm; and the van Herk margin recipes were 2.69 mm, 3.22 mm and 3.37 mm for the RL, SI and AP axes, respectively. Conclusion: The setup errors and inter-fraction prostate movements were small. Gold seed implantation is a feasible and easy method of verifying the prostate position.
引用
收藏
页码:405 / 409
页数:5
相关论文
共 50 条
  • [21] MANAGED CARE AND THE DIFFUSION OF INTENSITY-MODULATED RADIOTHERAPY FOR PROSTATE CANCER
    Jacobs, Bruce L.
    Zhang, Yun
    Hollenbeck, Brent K.
    JOURNAL OF UROLOGY, 2012, 187 (04): : E735 - E735
  • [22] Hypofractionated intensity-modulated radiotherapy effective in localized prostate cancer
    Alexandra King
    Nature Clinical Practice Urology, 2006, 3 (2): : 69 - 69
  • [23] Cost-effectiveness of Intensity-modulated Radiotherapy in Prostate Cancer
    Yong, J. H. E.
    Beca, J.
    McGowan, T.
    Bremner, K. E.
    Warde, P.
    Hoch, J. S.
    CLINICAL ONCOLOGY, 2012, 24 (07) : 521 - 531
  • [24] Managed Care and the Diffusion of Intensity-modulated Radiotherapy for Prostate Cancer
    Jacobs, Bruce L.
    Zhang, Yun
    Skolarus, Ted A.
    Wei, John T.
    Montie, James E.
    Schroeck, Florian R.
    Hollenbeck, Brent K.
    UROLOGY, 2012, 80 (06) : 1236 - 1242
  • [25] Acute toxicity of hypofractionated intensity-modulated radiotherapy for prostate cancer
    Drodge, C. S.
    Boychak, O.
    Patel, S.
    Usmani, N.
    Amanie, J.
    Parliament, M. B.
    Murtha, A.
    Field, C.
    Ghosh, S.
    Pervez, N.
    Current Oncology, 2015, 22 (02) : E76 - E84
  • [26] Inverse planning and intensity-modulated radiotherapy in patients with prostate cancer
    Debus, J
    Zierhut, D
    Didinger, B
    Schlegel, W
    Wannenmacher, M
    CONTROVERSIES IN URO-ONCOLOGY, 2002, 36 : 25 - 34
  • [27] Conventional versus hypofractionated intensity-modulated radiotherapy for Prostate cancer
    Pahl, R.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (09) : 841 - 842
  • [28] Image-guided intensity-modulated radiotherapy of prostate cancer
    Rudat, Volker
    Nour, A.
    Hammoud, M.
    Alaradi, A.
    Mohammed, A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 (02) : 109 - 117
  • [29] Is there an association between inter-fraction motion during prostate SABR and quality of life?
    Houlihan, Orla A.
    Clarke, Niamh
    Agnew, Christina
    McLaughlin, Owen
    Lyons, Ciara
    Cole, Aidan
    O'Sullivan, Joe
    Prise, Kevin M.
    Hounsell, Alan R.
    Mitchell, Darren M.
    McGarry, Conor
    Jain, Suneil
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2572 - S2576
  • [30] Magnetic resonance assessment of prostate localization variability in intensity-modulated radiotherapy for prostate cancer
    Villeirs, GM
    De Meerleer, GO
    Verstraete, KL
    De Neve, WJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (05): : 1611 - 1621